Extension Study of Ataluren in Participants With Nonsense Mutation Cystic Fibrosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Joseph McIntosh, MD
PTC Therapeutics
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
70 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitario Austral
Buenos Aires, Argentina
- Hospital de Ninos Ricardo Gutierrez
Buenos Aires, Argentina
- Royal Adelaide Hospital
Adelaide, Australia
- Prince Charles Hospital
Chermside, Australia
- Princess Margaret Hospital
Perth, Australia
- Hopital Universitaire Des Enfants Reine Fabiola
Brussels, Belgium
- University Hospital Brussels
Brussels, Belgium
- University Hospital Leuven
Leuven, Belgium
- Hospital Sao Lucas Da Pontificia Universidade Catolica Do Rio Grande Do Sul
Porto Alegre, Brazil
- University Mulitiprofile Hospital for Active Treatment Sveti Georgi Ead
Plovdiv, Bulgaria
- University Multiprofile Hospital for Active Treatment Aleksandrovska Ead
Sofia, Bulgaria
- Clinical Research Institute of Montreal
Montreal, Canada
- University of Toronto Hospital for Sick Children
Toronto, Canada
- British Columbia Children'S Hospital
Vancouver, Canada
- Hoptial Arnaud de Villeneuve
Montpellier, France
- Hopital Necker - Enfants Malades
Paris, France
- Centre de Perharidy
Roscoff, France
- Centre Hospitalier Regional Sud Reunion
Saint-Pierre, France
- Charite-Universitatsmedizin Berlin
Berlin, Germany
- St. Josef Hospital Gmbh
Bochum, Germany
- University of Cologne Children'S Hospital
Cologne, Germany
- Christiane Herzog Cf-Zentrum
Frankfurt am Main, Germany
- Universitatsklinikum Jena
Jena, Germany
- Lmu Klinikum Der Universitat Muchen
Munich, Germany
- Dr. Von Haunersches Kinderspital
München, Germany
- Ippokratio General Hospital of Thessaloniki
Thessaloniki, Greece
- Meyer Children'S Hospital
Haifa, Israel
- Hadassah University Hospital
Jerusalem, Israel
- Azienda Ospedaliero Universitaria Ospedall Riuniti Di Acona-Umberto I G.M. Lancisi G. Salesi
Ancona, Italy
- Azienda Ospedaliera A Meyer
Florence, Italy
- Lombardia Cystic Fibrosis Center
Milan, Italy
- Azienda Policlinico Umberto I
Rome, Italy
- Ospedale Pediatrico Bambino Gesu
Rome, Italy
- Azienda Ospedaliera Di Verona
Verona, Italy
- Hagaziekenhuis
s-Gravenweg, South Holland, Netherlands
- Radboud University
Nijmegen, Netherlands
- Szpital Dzieciecy Polanki Im Macieja Plazynskiego W Gdansku
Gdansk, Poland
- Institute of Mother and Child
Warsaw, Poland
- Hospital Universitario Vall D'Hebron
Barcelona, Spain
- Hospital University
Barcelona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2015
- Primary completion
- 2 Jun 2017
- Completion
- 2 Jun 2017
- Last update posted
- 27 Apr 2020
- Registered enrollment
- 246
- Registry id
- NCT02456103
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.